-
Dr. Oliver Aalami Director Biodesign Digital Health, Stanford University
Dr. Oliver Aalami is a Clinical Professor of Vascular and Endovascular Surgery at Stanford University, leading Stanford Biodesign's Digital Health unit. He focuses on developing scalable digital healthcare solutions to improve access and outcomes. As co-founder of Spezi, an open-source mobile health research framework, he works to accelerate digital health adoption through innovative reimbursement models for predictive & preventative technologies. Through education and the integration of advanced technologies with clinical practice, Dr. Aalami is transforming how real-world patient data enhances care delivery. -
Brenya Adjei Managing Director, gematik GmbH
Brenya Adjei joined gematik's Executive Board on September 1, 2024, overseeing Human Resources, IT, and Communications. Before this, she served as Chief Customer Officer at Dina Elektronik, where she focused on digitalizing customer experiences, crafting product strategies, and implementing New Work methods. With a media management degree, Brenya has over 15 years of agency experience, including a role as Director of Innovation & Strategy at the diffferent strategy agency. She has advised major companies like Deutsche Telekom, Porsche, and Nivea on digitalization. Her expertise lies in developing customer-centric products,
communication strategies, and leading diverse teams. Brenya Adjei on LinkedIn -
-
-
-
Inga Bergen Visionary entrepreneur, investor, and digital health expert
Inga Bergen is a visionary entrepreneur, investor, and digital health expert dedicated to transforming the healthcare industry. She has led groundbreaking projects, including heading Welldoo, the first service provider for health apps, and contributing to the growth of Fjord, later acquired by Accenture. Inga is an active investor, supporting startups that drive innovation and positive change in healthcare. As the host of the podcast Visionäre der Gesundheit, she interviews thought leaders shaping the future of health. Inga Bergen on LinkedIn -
-
-
-
-
-
-
-
Prof. Dr. Melinda Buntin Bloomberg Distinguished Professor of Health Policy and Economics, Johns Hopkins University
Melinda J.B. Buntin, Ph.D., is a health economist and Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Carey Business School. She directs the Center for Health Systems and Policy Modeling, based in Washington DC. Previously, she was founding Chair of the Department of Health Policy at Vanderbilt University, Director of the Office of Economic Analysis, Evaluation, and Modeling at the Office of the National Coordinator for Health Information Technology at the US Department of Health and Human Services, and Deputy Director of Health, Retirement and Long-Term Analysis at the Congressional Budget Office. Melinda Buntin on LinkedIn -
Michael Byczkowski Global Vice President, SAP SE
Michael Byczkowski is Global Vice President at SAP SE, focusing on innovations in healthcare and adjacent industries. Michael’s key motivation is to help create sustainable business value and contribute to improving people’s lives. With more than twenty-five years of experience in IT and consulting, Michael has a broad background in customer engagements, business development, strategic alliances management, and developer/platform strategy. After finishing his diploma in Mathematics, Michael started his professional career at a German utility company, focusing on Business Process Reengineering and Privacy/Data Security. Twenty years ago, he joined SAP’s Industry Business Unit for the utilities industry, working abroad in Singapore for three years where he was leading the regional product management for Asia-Pacific and Japan. Following this assignment, Michael headed the Microsoft global alliance team at SAP for nine years and established the joint SAP-Microsoft Collaboration Technology Support Center before leading the Gateway strategy, a technology that provides a simple way to connect devices, environments and platforms to SAP software based on market standards, of SAP’s global ecosystem organization. Having spent five years, focusing on strategic customer projects to demonstrate innovative methods and approaches for creating tangible value, Michael took over the global responsibility for SAP’s industry business in healthcare and focuses on strategic customer and partner engagements. Michael lives in Walldorf, Germany. Michael Byczkowski on LinkedIn -
-
-
-
-
-
-
Silke Gebel Member of the Berlin state Parliament
Silke Gebel is a member of the Berlin state Parliament, a position she has held since 2013. She is the Chair of the Healthcare Committee and a member of the Budget committee. She was the spokesperson for environmental policy and a member of the Enquete Commission for Renewable Energies until 2016. During the Government of the social democrats, greens and leftwing parties between 2016 and 2023, she was the parliamentary group leader of the Greens. Silke holds a degree in administrative science from University of Göttingen and Potsdam. She is born in 1983, is married, and the mother of three children. -
-
-
-
Dr. Marelize Gorgens Lead: Digital and AI for Human Capital, World Bank
At the World Bank, Marelize focuses on innovation, digital technology, AI, and human development. She has supported low- and middle-income countries globally with evidence, technical advice, and implementation know-how. Marelize serves on the Editorial Boards of Oxford Digital Health and Global Health Science and Practice. Her research emphasizes the value of digital and data technologies for human development. Before the Bank, she worked on large-scale health and education sector digital transformations in Africa, Asia, and Eastern Europe with leading private and non-governmental organizations. Marelize Gorgens on LinkedIn -
Thomas Hagemeijer Founder, HGM Advisory
Thomas Hagemeijer is the founder of HGM Advisory, a HealthTech consultancy supporting senior leaders in healthcare innovation. He collaborates across pharma, MedTech, investors, startups, hospitals, and policymakers, focusing on business models, go-to-market strategies, and commercial due diligence. As a business angel with the Springboard Health Angels group, Thomas invests in early-stage AI and HealthTech startups. He is also an ambassador for HLTH Europe, the leading HealthTech conference, and his LinkedIn posts on HealthTech and AI reach over 2 million people annually. A sought-after speaker and moderator, Thomas is a key
voice in healthcare innovation. Thomas Hagemeijer on LinkedIn -
Prof. Dr. Lutz Hager Professor for Healthcare Management, SRH Fernhochschule
Prof. Dr. Lutz Hager is professor for healthcare management at SRH Fernhochschule – The Distance Learning University. He also serves as Chairman of the Board of the German Managed Care Association and as Vice-Chair of the Gesundheitsplattform Rhein-Neckar. He is a fellow of Sciana – The Health Leaders Network. From 2019-2021, he held a position as Managing Director of a group of ambulatory care practices; previously he served for eight years as Executive Director of regional payor IKK Südwest. He is a political scientist by training and holds a degree from Free University of Berlin and Sciences Po Paris. After his Ph.D. he spent six years with McKinsey&Co. as a consultant. -
-
-
-
Dr. Valerie Kirchberger Co-founder, Evela Health
Valerie is a physician, healthcare innovator, and co-founder of Evela Health, a company dedicated to transforming women's health over forty through personalized, data-driven solutions. With a career spanning roles at leading institutions like Charité – Universitätsmedizin Berlin and as Chief Medical Officer at Heartbeat Medical, Valerie has developed deep expertise in value-based healthcare and the integration of digital tools into complex health systems.Her work has focused on improving outcomes by leveraging data, rethinking traditional care models, and addressing the inefficiencies of one-size-fits-all approaches. At Evela Health, she is applying this experience to create a healthcare future that is intelligent, proactive, and grounded in measurable impact. Valerie Kirchberger on LinkedIn -
-
Prof. Helene Kretzmer Head of "Computational Genomics", HPI
Prof. Kretzmer is a bio-mathematician by training with core expertise in bioinformatics, having completed her Postdoctoral training at the Max Planck Institute for Molecular Genetics. In October 2024, she was appointed Chair of Computational Genomics at the Hasso Plattner Institute. Her research focuses on the integration of multi-modal sequencing data, machine learning, and software development to bridge basic and translational research. She is particularly interested in understanding the molecular underpinnings of diseases and leveraging this knowledge to improve patient care, which makes her work highly interdisciplinary, with close collaboration between clinicians and biologists. -
-
Dr. Katharina Ladewig Managing Director of the Center for Artificial Intelligence in Public Health Research, RKI
Dr. Katharina Ladewig is the Managing Director of the Center for Artificial Intelligence in Public Health Research (ZKI-PH) at the Robert Koch Institute, Germany’s National Public Health Institute. Her main focus is to establish ZKI-PH as a recognized center for AI-supported public health research. She oversees five research groups in AI Fundamentals, Phylogenomics, Image Analysis, Climate & Societal Analysis, and Visualization, while managing research collaborations, funding strategies, project management, and science communication. Prior to her role at the Robert Koch Institute, Dr. Ladewig served as Managing Director for EIT Health UK-Ireland and EIT Health Germany, contributing to a European network aimed at advancing healthcare innovations. She has significant experience managing international research projects in pharmaceuticals, biotechnology, and health, and has led partnerships between industry and academia in Germany and Australia. -
-
-
-
Erik Lium, PhD Chief Commercial Innovation Officer, Mount Sinai Health System
President, Mount Sinai Innovation Partners
Erik Lium, PhD, is the Chief Commercial Innovation Officer for the Mount Sinai Health System and the President of Mount Sinai Innovation Partners (MSIP). Dr. Lium is responsible for advancing Mount Sinai’s research, instruction, and public service missions through strategic research partnerships with industry, the management, transfer, and commercialization of Mount Sinai technologies, and fostering the development of startups to advance promising early-stage technologies. Under Dr. Lium’s leadership and through Mount Sinai’s expansive network of industry partnerships Erik Lium on LinkedIn -
Betsabeh Madani Hermann Global Head of Research, Philips
Betsabeh Madani-Hermann is the Global Head of Research at Philips. She is the executive responsible for building, managing and funding the breakthrough and exploratory innovations across all business segments. Initially, she joined Philips as the Global Head of Strategy and Business Development for Connected Care, a €7 billion revenue portfolio. Before, Betsabeh held roles in robotics, healthcare, and biotech, managing market caps from $5M to $30B. Betsabeh holds an MBA, a Master’s in Bio-Mechanical Engineering, and graduate research in proteomics. Additionally, she has been an Adjunct Professor at UBC’s Graduate School of Engineering and is a Brain Trust at XPRIZE. Betsabeh Madani-Hermann on LinkedIn -
-
Prof. Dr. Mandy Mangler Senior President, Society for Gynecology and Obstetrics Berlin (GGGB)
Mandy Mangler studied human medicine at the Free University of Berlin. From 2004 to 2016, she worked in gynecology and obstetrics at Charité, initially at the Benjamin Franklin Clinic and from 2006 at Charité Mitte. From 2013 to 2014, she was interim Head of Gynecology at Charité Mitte, making her the first and so far only woman to be Head of Gynecology at Charité. In 2005, she completed her doctorate on the “Therapy of rectovaginal endometriosis”. In 2013, she habilitated on the topic of “Fertility-preserving laparoscopic therapy strategies in patients with gynecological diseases”. Since September 1, 2016, she has been Chief Physician for Gynaecology and Obstetrics at Vivantes Auguste-Viktoria Hospital in Berlin and since January 1, 2021 at the maximum care provider Vivantes Neukölln Hospital. Mandy Mangler is Senior President of the Society for Gynecology and Obstetrics Berlin and Chairwoman of the Berlin Chief Physicians of the BLFG e. V., the Federal Working Group of Chief Physicians in Obstetrics and Gynecology e. V. Since 2021, she has been teaching as Professor of Women's Health and Obstetrics at the Protestant University of Applied Sciences Berlin. She received the Berlin Women's Prize in 2022 and the State Order of the City of Berlin in 2024. Mandy Mangler on LinkedIn -
-
Igor Matias Ph.D. student, University of Geneva
Igor Matias is a Ph.D. student at the University of Geneva, Switzerland, focusing on digital biomarkers of cognitive performance fluctuations, advancing the passive and early detection of Alzheimer's Disease. His work combines wearable sensor data with smartphone-based assessments to track real-world behaviors in naturalistic settings, enabling scalable and passive monitoring. Computer scientist and engineer by training, he bridges artificial intelligence, cognitive aging, and digital health, emphasizing data sharing and interdisciplinary collaboration, contributing to innovative tools that advance mental health research and personalized healthcare solutions for tomorrow's population. Igor Matias on LinkedIn -
-
-
-
Timo Minssen Professor of Law, University of Copenhagen
Timo Minssen is Professor of Law, specializing in Health & Life Science Innovation, at the University of Copenhagen (UCPH). He is the Founding Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL). He is also an Inter-CeBIL/PFC affiliate at Harvard Law School and an LML Research Affiliate at the University of Cambridge. His research and advisory practice concentrates on Intellectual Property-, Competition, Data Protection & Regulatory Law with a special focus on new technologies in the health & life sciences including artificial intelligence and quantum technology. -
-
-
-
-
-
-
Dr. Franz MJ Pfister CEO & Co-founder, deepc
Dr. Franz MJ Pfister is a medical doctor, data scientist, and entrepreneur recognized as a leading expert in artificial intelligence, data-driven healthcare, and digital transformation. He studied medicine at Ludwig Maximilian University of Munich and Harvard Medical School, earning a doctorate in neuroscience. Additionally, he holds an MBA from Munich Business School and a Master’s degree in Data Science from LMU Munich. As the CEO and co-founder of deepc, a Munich-based AI platform company, he drives the development, deployment, and monitoring of next-generation Radiology AI solutions to enhance patient care, optimize clinical workflows, and enable personalized medicine. -
Nicholson Price, JD, PhD Professor of Law, University of Michigan Law School
Nicholson Price, JD, PhD, is a Professor of Law at the University of Michigan Law School, where he studies how law shapes biomedical innovation, especially in the area of artificial intelligence in medicine. He has spoken around the world on medical AI and published extensively on the topic. He teaches patent law, health law, AI law, and science fiction and the law. Nicholson is a Senior Fellow at the University of Copenhagen’s Center for Advanced Studies in Bioscience Innovation Law and a Celadon Fellow at the Center for Trustworthy AI at Seoul National University. Nicholson Price on LinkedIn -
-
-
-
-
-
-
-
-
-
-
Eric Sutherland Senior Health Economist, OECD
Eric is a Senior Health Economist leading the OECD’s work in Digital Health, bringing together policy guidance for digital tools, integrated data, and responsible analytics including artificial intelligence. In that role, he is accountable for measuring and evolving the OECD’s Recommendation on Health Data Governance (2016) and supporting digital health policy that provides data protection (e.g. security and privacy) and timely access to quality data to optimize the use of data for information, insights, and impact among individuals, health workers, policy makers, researchers, and innovators. Eric Sutherland on LinkedIn -
-
Prof. Sandra Wachter Professor of Technology and Regulation at the Oxford Internet Institute, University of Oxford
Sandra Wachter is Professor of Technology and Regulation at the Oxford Internet Institute at the University of Oxford. Her research focuses on profiling, inferential analytics, explainable AI, algorithmic bias, and fairness, as well as governmental surveillance, predictive policing, human rights online and health tech and medical law.
At the OII, Professor Sandra Wachter leads and coordinates the Governance of Emerging Technologies Research Programme that investigates legal, ethical, and technical aspects of AI, and other emerging technologies.
Professor Wachter also serves as a policy advisor for governments, companies, and NGO’s around the world on regulatory and ethical questions concerning emerging technologies. Sandra Wachter on LinkedIn -
-
-
-
